iAltitude is a Spanish biotech company founded in 2015, specializing in the development of software and hardware for human performance and simulated altitude systems. The company has pioneered the creation of software capable of collecting and analyzing individualized physiological data, such as pulse and oximetry levels, to schedule personalized altitude training sessions. This innovative approach eliminates the need for costly expert trainers and allows for precise monitoring and adaptation of training programs based on the user's physiological reactions.
With a network of more than 40 centers, iAltitude has made altitude training more accessible, attracting interest from various sectors including healthcare, aerospace medicine, and sports. The company has gained traction among professional and amateur athletes who incorporate the iAltitude system into their training routines to improve performance and overall well-being.
Despite the promising potential, iAltitude does not have publicly disclosed last investment details or known investors at this time. However, the company's innovative technology and market presence position it as an intriguing prospect for potential investors seeking exposure to the biotech and performance enhancement sectors in Spain.
There is no investment information
No recent news or press coverage available for iAltitude .